Details for New Drug Application (NDA): 040627
✉ Email this page to a colleague
The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the benzonatate profile page.
Summary for 040627
Tradename: | BENZONATATE |
Applicant: | Thepharmanetwork Llc |
Ingredient: | benzonatate |
Patents: | 0 |
Pharmacology for NDA: 040627
Physiological Effect | Decreased Tracheobronchial Stretch Receptor Activity |
Suppliers and Packaging for NDA: 040627
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BENZONATATE | benzonatate | CAPSULE;ORAL | 040627 | ANDA | RPK Pharmaceuticals, Inc. | 53002-5890 | 53002-5890-1 | 10 CAPSULE in 1 BOTTLE (53002-5890-1) |
BENZONATATE | benzonatate | CAPSULE;ORAL | 040627 | ANDA | RPK Pharmaceuticals, Inc. | 53002-5890 | 53002-5890-2 | 20 CAPSULE in 1 BOTTLE (53002-5890-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Mar 30, 2007 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Jul 25, 2007 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
Approval Date: | Sep 24, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription